Literature DB >> 24778416

Lipid metabolism signatures in NASH-associated HCC.--letter.

Sonja M Kessler1, Stephan Laggai1, Ahmad Barghash1, Volkhard Helms1, Alexandra K Kiemer2.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24778416     DOI： 10.1158/0008-5472.CAN-13-2852

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  8 in total

1.  The IGF2 mRNA binding protein p62/IGF2BP2-2 induces fatty acid elongation as a critical feature of steatosis.

Authors:  Stephan Laggai; Sonja M Kessler; Stefan Boettcher; Valérie Lebrun; Katja Gemperlein; Eva Lederer; Isabelle A Leclercq; Rolf Mueller; Rolf W Hartmann; Johannes Haybaeck; Alexandra K Kiemer
Journal:  J Lipid Res       Date:  2014-04-22       Impact factor: 5.922

2.  Comments on "NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis".

Authors:  Guangbing Li; Li Yuan; Jun Liu; Haitao Zhao
Journal:  Hepatobiliary Surg Nutr       Date:  2016-12       Impact factor: 7.293

3.  Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis.

Authors:  Yvette Simon; Sonja M Kessler; Katja Gemperlein; Rainer M Bohle; Rolf Müller; Johannes Haybaeck; Alexandra K Kiemer
Journal:  World J Gastroenterol       Date:  2014-12-21       Impact factor: 5.742

Review 4.  Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play.

Authors:  Bérénice Charrez; Liang Qiao; Lionel Hebbard
Journal:  World J Gastroenterol       Date:  2016-02-28       Impact factor: 5.742

5.  IMP2/p62 induces genomic instability and an aggressive hepatocellular carcinoma phenotype.

Authors:  S M Kessler; S Laggai; A Barghash; C S Schultheiss; E Lederer; M Artl; V Helms; J Haybaeck; A K Kiemer
Journal:  Cell Death Dis       Date:  2015-10-01       Impact factor: 8.469

6.  Fatty acid elongation in non-alcoholic steatohepatitis and hepatocellular carcinoma.

Authors:  Sonja M Kessler; Yvette Simon; Katja Gemperlein; Kathrin Gianmoena; Cristina Cadenas; Vincent Zimmer; Juliane Pokorny; Ahmad Barghash; Volkhard Helms; Nico van Rooijen; Rainer M Bohle; Frank Lammert; Jan G Hengstler; Rolf Mueller; Johannes Haybaeck; Alexandra K Kiemer
Journal:  Int J Mol Sci       Date:  2014-04-04       Impact factor: 5.923

7.  Elovl6 is a negative clinical predictor for liver cancer and knockdown of Elovl6 reduces murine liver cancer progression.

Authors:  Yu-Chu Su; Yin-Hsun Feng; Hung-Tsung Wu; Yao-Shen Huang; Chao-Ling Tung; Pensee Wu; Chih-Jen Chang; Ai-Li Shiau; Chao-Liang Wu
Journal:  Sci Rep       Date:  2018-04-26       Impact factor: 4.379

8.  The mRNA-binding Protein TTP/ZFP36 in Hepatocarcinogenesis and Hepatocellular Carcinoma.

Authors:  Tarek Kröhler; Sonja M Kessler; Kevan Hosseini; Markus List; Ahmad Barghash; Sonika Patial; Stephan Laggai; Katja Gemperlein; Johannes Haybaeck; Rolf Müller; Volkhard Helms; Marcel H Schulz; Jessica Hoppstädter; Perry J Blackshear; Alexandra K Kiemer
Journal:  Cancers (Basel)       Date:  2019-11-08       Impact factor: 6.639
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.